Daiichi Sankyo to acquire Zepharma from Astellas
TOKYO, Japan - Takashi Shoda (R), president of Daiichi Sankyo Co., and Masaji Oe, president of Zepharma Inc., stellas Pharma Inc.'s nonprescription drug unit, shake hands at a news conference at Daiichi Sankyo's head office in Tokyo on March 31. They announced Daiichi Sankyo will buy Zepharma for 23.5 billion yen. (Kyodo)
- Product Code
- ILEA000032103
- Registered date
- 2006/3/31 00:00:00
- Credit
- Kyodo / Kyodo News Images
- Media size
- 1228 × 1764 pixel
- Deployment size
- 309.59(KB)*
*File size when opened in Photoshop, etc.